Venus Concept Inc
VERO2.495USD
-0.025-0.99%
交易中 （美东）报价延迟15分钟
1.77M总市值
亏损市盈率 TTM
关于 Venus Concept Inc 公司
Venus Concept Inc. 是一家全球医疗技术公司。该公司开发、商业化并提供微创和非侵入性医学美容和头发修复技术及相关服务，业务覆盖 60 多个国家和 10 个直接市场。该公司的产品组合包括美容设备平台，包括 Venus Versa、Venus Versa Pro、Venus Legacy、Venus Velocity、Venus Viva、Venus Glow、Venus Bliss、Venus Bliss MAX、Venus Epileve、Venus Viva MD 和 AI.ME。其脱发治疗分为非手术治疗和手术治疗。其头发修复系统包括 NeoGraft 和 ARTAS iX 机器人头发修复系统。其系统设计在灵活的平台上，使其能够扩展到美容行业传统的皮肤病学和整形外科市场之外，并进入非传统市场，包括家庭医学和全科医生以及美容医疗水疗中心。
公司简介
公司代码VERO
公司名称Venus Concept Inc
上市日期Oct 12, 2017
CEOMr. Rajiv De Silva
员工数量292
证券类型Ordinary Share
年结日Oct 12
公司地址235 Yorkland Blvd Suite 900
城市TORONTO
上市交易所NASDAQ Capital Market Consolidated
国家Canada
邮编M2J 4Y8
电话18778488430
网址https://www.venusconcept.com/en-uk/
公司代码VERO
上市日期Oct 12, 2017
CEOMr. Rajiv De Silva
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Kirk Gunhus
Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
--
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+0.13%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+0.64%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
Ms. Melissa Kang, CPA
Ms. Melissa Kang, CPA
Chief Product Officer
Chief Product Officer
--
--
Ms. Louise M. Lacchin
Ms. Louise M. Lacchin
Independent Director
Independent Director
--
--
Mr. Scott Barry
Mr. Scott Barry
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Domenic Della Penna, CPA
Mr. Domenic Della Penna, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Kirk Gunhus
Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
--
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+0.13%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+0.64%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Products—Systems
7.90M
57.93%
Subscription—Systems
2.65M
19.42%
Products—Other
2.42M
17.74%
Services
671.00K
4.92%
地区USD
名称
营收
占比
United States
8.41M
61.62%
International
5.24M
38.38%
业务
地区
业务USD
名称
营收
占比
Products—Systems
7.90M
57.93%
Subscription—Systems
2.65M
19.42%
Products—Other
2.42M
17.74%
Services
671.00K
4.92%
股东统计
更新时间: 7月15日 周二
更新时间: 7月15日 周二
持股股东
股东类型
持股股东
持股股东
占比
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
Madryn Asset Management, LP
0.55%
UBS Financial Services, Inc.
0.49%
Other
85.94%
持股股东
持股股东
占比
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
Madryn Asset Management, LP
0.55%
UBS Financial Services, Inc.
0.49%
Other
85.94%
股东类型
持股股东
占比
Venture Capital
7.54%
Investment Advisor
5.97%
Individual Investor
0.82%
Private Equity
0.55%
Hedge Fund
0.10%
Other
85.03%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
48
303.41K
16.32%
+73.80K
2025Q1
57
222.57K
25.52%
+13.74K
2024Q4
59
229.67K
34.82%
+28.01K
2024Q3
64
3.05M
44.61%
-537.66K
2024Q2
70
3.54M
52.45%
+304.55K
2024Q1
74
3.18M
52.95%
-445.34K
2023Q4
77
2.92M
53.20%
-420.44K
2023Q3
87
3.15M
119.91%
-295.52K
2023Q2
98
3.14M
119.96%
-1.42M
2023Q1
124
4.18M
259.89%
-397.96K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Orca Capital GmbH
101.75K
5.47%
+101.75K
--
Jun 06, 2025
EW Healthcare Partners
99.02K
5.33%
+3.00
+0.00%
Jun 09, 2025
HealthQuest Capital Management, L.P
41.19K
2.22%
--
--
Dec 31, 2024
Madryn Asset Management, LP
10.19K
0.55%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
9.19K
0.49%
+4.02K
+77.78%
Mar 31, 2025
De Silva (Rajiv)
7.58K
0.41%
--
--
Apr 28, 2025
Tower Research Capital LLC
1.78K
0.1%
+1.14K
+176.28%
Mar 31, 2025
Hollmig (Stanley Tyler)
1.76K
0.09%
--
--
Apr 28, 2025
Gunhus (Kirk)
1.64K
0.09%
+1.64K
--
Apr 28, 2025
Varghese (Hemanth Jacob)
1.52K
0.08%
+1.00
+0.07%
Apr 28, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
公告日期
类型
比率
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
